YH-004

N/A

Report date: 2023/12/08 11:56:38

Base Information

Drug NameYH-004
Drug Alias NameYH-004
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionTumor necrosis factor receptor superfamily member 9 agonists
TargetsTumor necrosis factor receptor superfamily member 9
Therapy Area/IndicationsSolid tumoursLymphoma, Non-HodgkinNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesEucure Pharmaceutical Technology (Beijing) Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesEucure Pharmaceutical Technology (Beijing) Co Ltd
Inactive CompaniesBiocytogen Pharmaceuticals (Beijing) Co Ltd
Active IndicationsSolid tumoursLymphoma, Non-HodgkinNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A